Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. (EGX: RMDA)
Egypt
· Delayed Price · Currency is EGP
3.660
0.00 (0.00%)
At close: Oct 15, 2024
RMDA Revenue
Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. had revenue of 564.91M EGP in the quarter ending June 30, 2024, with 25.41% growth. This brings the company's revenue in the last twelve months to 2.10B, up 30.11% year-over-year. In the year 2023, Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. had annual revenue of 1.92B with 29.54% growth.
Revenue (ttm)
2.10B
Revenue Growth
+30.11%
P/S Ratio
2.60
Revenue / Employee
n/a
Employees
n/a
Market Cap
5.50B
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition